Gerresheimer AG (ETR:GXI – Get Free Report)’s share price rose 1.4% on Thursday . The stock traded as high as €75.95 ($81.67) and last traded at €75.40 ($81.08). Approximately 194,688 shares changed hands during trading, an increase of 38% from the average daily volume of 140,925 shares. The stock had previously closed at €74.35 ($79.95).
Gerresheimer Price Performance
The stock has a market cap of $2.58 billion, a PE ratio of 22.59, a P/E/G ratio of 0.82 and a beta of 0.94. The business has a fifty day simple moving average of €75.29 and a two-hundred day simple moving average of €79.00. The company has a current ratio of 0.80, a quick ratio of 0.40 and a debt-to-equity ratio of 87.94.
Gerresheimer Company Profile
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Read More
- Five stocks we like better than Gerresheimer
- How to Calculate Options Profits
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- What Are Dividend Champions? How to Invest in the Champions
- Top 3 Beverage Stocks Pouring Out Profits
- What is the Australian Securities Exchange (ASX)
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.